In appropriate patients,

PREVYMIS can help protect against cytomegalovirus (CMV) disease

PREVYMIS is a prescription medicine used to help prevent:

CMV infection and disease in adults who have received an allogeneic hematopoietic stem cell (bone marrow) transplant and who have a high risk for getting CMV infection and disease. It is not known if PREVYMIS is safe and effective in children under 18 years of age.

Learn More >

CMV disease in adults who have received a kidney transplant and who have a high risk for getting CMV disease. It is not known if PREVYMIS is safe and effective in children under 18 years of age.

Learn More >

Learn more about CMV infection and disease

Pay as little as $15 for PREVYMIS tablets*

For eligible, privately insured patients

View savings offer
*Eligible, privately insured patients may pay as little as $15 per prescription on each of up to 8 qualifying prescriptions for up to a one-month’s supply per prescription. Maximum savings is $2,500 per prescription. Not valid for patients who are uninsured or patients with Medicare or other Government Program insurance. Not all patients are eligible. Certain restrictions apply. See Terms and Conditions.

What is PREVYMIS® (letermovir)?

PREVYMIS is a prescription medicine used to help prevent:

  • Cytomegalovirus (CMV) infection and disease in adults who have received an allogeneic hematopoietic stem cell (bone marrow) transplant and who have a high risk for getting CMV infection and disease.
  • CMV disease in adults who have received a kidney transplant and who have a high risk for getting CMV disease.

It is not known if PREVYMIS is safe and effective in children under 18 years of age.

Important Safety Information

Do not take PREVYMIS if you take pimozide or ergot alkaloids.

 

If you are taking PREVYMIS with cyclosporine, do not take pitavastatin or simvastatin.

 

Before taking PREVYMIS, tell your healthcare provider about all your medical conditions, including if you have kidney or liver problems; are pregnant or plan to become pregnant, since it is not known if PREVYMIS will harm your unborn baby; and if you are breastfeeding or plan to breastfeed, since it is not known if PREVYMIS passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while taking PREVYMIS.

 

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. PREVYMIS may affect the way other medicines work, and other medicines may affect how PREVYMIS works and can cause serious side effects.

 

Know the medicines you take. Keep a list of medicines and show it to your healthcare provider and pharmacist when you get a new medicine. Your healthcare provider or pharmacist will tell you if it is safe to take PREVYMIS with other medicines. Do not start or stop taking another medicine without telling your healthcare provider first.

 

The most common side effects of PREVYMIS in adults who have received a hematopoietic stem cell transplant include: nausea, diarrhea, vomiting, swelling in your arms and legs, cough, headache, tiredness, and stomach (abdominal) pain.

 

The most common side effect of PREVYMIS in adults who have received a kidney transplant is diarrhea.

 

These are not all the possible side effects of PREVYMIS.

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

 

Please read the accompanying Patient Information for PREVYMIS, and discuss it with your healthcare professional.

 

The Physician Prescribing Information also is available.

What is PREVYMIS® (letermovir)?

PREVYMIS is a prescription medicine used to help prevent:

  • Cytomegalovirus (CMV) infection and disease in adults who have received an allogeneic hematopoietic stem cell (bone marrow) transplant and who have a high risk for getting CMV infection and disease.
  • CMV disease in adults who have received a kidney transplant and who have a high risk for getting CMV disease.

It is not known if PREVYMIS is safe and effective in children under 18 years of age.

PREVYMIS is a prescription medicine used to help prevent:

  • Cytomegalovirus (CMV) infection and disease in adults who have received an allogeneic

PREVYMIS is a prescription medicine used to help prevent:

  • Cytomegalovirus (CMV) infection and disease in adults who have received an allogeneic hematopoietic stem cell (bone marrow) transplant and who have a high risk for getting CMV infection and disease.
  • CMV disease in adults who have received a kidney transplant and who have a high risk for getting CMV disease.

Important Safety Information for PREVYMIS® (letermovir)

Do not take PREVYMIS if you take pimozide or ergot alkaloids.

 

If you are taking PREVYMIS with cyclosporine, do not take pitavastatin or simvastatin.

 

Before taking PREVYMIS, tell your healthcare provider about all your medical conditions, including if you have kidney or liver problems; are pregnant or plan to become pregnant, since it is not known if PREVYMIS will harm your unborn baby; and if you are breastfeeding or plan to breastfeed, since it is not known if PREVYMIS passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while taking PREVYMIS.

 

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. PREVYMIS may affect the way other medicines work, and other medicines may affect how PREVYMIS works and can cause serious side effects.

 

Know the medicines you take. Keep a list of medicines and show it to your healthcare provider and pharmacist when you get a new medicine. Your healthcare provider or pharmacist will tell you if it is safe to take PREVYMIS with other medicines. Do not start or stop taking another medicine without telling your healthcare provider first.

 

The most common side effects of PREVYMIS in adults who have received a hematopoietic stem cell transplant include: nausea, diarrhea, vomiting, swelling in your arms and legs, cough, headache, tiredness, and stomach (abdominal) pain.

 

The most common side effect of PREVYMIS in adults who have received a kidney transplant is diarrhea.

 

These are not all the possible side effects of PREVYMIS.

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

 

Please read the accompanying Patient Information for PREVYMIS, and discuss it with your healthcare professional.

 

The Physician Prescribing Information also is available.

Do not take PREVYMIS if you take pimozide or ergot alkaloids.

Do not take PREVYMIS if you take pimozide or ergot alkaloids.

If you are taking PREVYMIS with cyclosporine, do not take pitavastatin or simvastatin.

Before taking PREVYMIS, tell your healthcare provider about all your medical conditions, including if you have kidney or liver problems; are pregnant or plan